Copy
Problems viewing this newsletter? View it in your browser >



New Issue of Px Wire

April 20, 2015
 
Dear Advocates,
 
The new issue of Px Wire, AVAC’s quarterly newsletter on HIV prevention research and implementation, is now available.
 
Click here to download.
 
In this issue, you’ll find:
  • Updates on how WHO is approaching broader guidance on oral PrEP—and what advocates think should happen next.
  • A closer look at passive immunization, an expanding area of research referring to the administration of laboratory-generated antibodies. Passive immunization is being explored in people living with HIV in attempts to help control viral replication and/or serve as part of a cure strategy. It is also being explored for HIV prevention.
  • And this issue’s centerspread provides a quick primer on passive immunization with HIV-specific antibodies, long-acting antiretroviral injectables, and preventive vaccines, including a new, informative table reviewing the pipelines in research and development for all three research avenues.
The full issue of Px Wire, as well as our archive of old issues and information on ordering print copies, can be found at www.avac.org/pxwire.

As always, we welcome your questions and comments at avac@avac.org.

Best,
AVAC

UPCOMING WEBINAR

April 21: New Frontiers in HIV Prevention, Treatment and CureDr. Sarah Schlesinger, of Rockefeller University, will provide an overview of recent developments in passive immunization including new published data. She and other resource people will be on hand to take questions. This webinar is the next in our year-long series of web-based dialogues that is delving into issues raised in our recent AVAC Report, Prevention on the Line. Links to recordings and slides from the other calls in the series are at HIV Prevention the Line.

JOIN US >



Forward This IssueDo you know someone who might be interested in receiving this newsletter?
Forward > 


Unsubscribe You're receiving this because you signed up for our newsletter. Not interested any longer?
Unsubscribe > 


Contact Us T: +1 212 796 6423
E: avac@avac.org

W: www.avac.org